APA (7th ed.) Citation

SJ, W., K, O., MT, G., C, Y., H, D., M, G., . . . V, G. (2023). Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 49(10), 106934. https://doi.org/10.1016/j.ejso.2023.05.009

Chicago Style (17th ed.) Citation

SJ, Withey, et al. "Association of Dynamic Contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT Parameters with Neoadjuvant Therapy Response and Survival in Esophagogastric Cancer." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 49, no. 10 (2023): 106934. https://doi.org/10.1016/j.ejso.2023.05.009.

MLA (9th ed.) Citation

SJ, Withey, et al. "Association of Dynamic Contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT Parameters with Neoadjuvant Therapy Response and Survival in Esophagogastric Cancer." European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, vol. 49, no. 10, 2023, p. 106934, https://doi.org/10.1016/j.ejso.2023.05.009.